BACTERIAL INFECTIONS
Clinical trials for BACTERIAL INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new BACTERIAL INFECTIONS trials appear
Sign up with your email to follow new studies for BACTERIAL INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shield blood cancer patients from deadly infections
Disease control Recruiting nowThis study tests whether adding XEMBIFY to standard treatment can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody levels. About 386 participants will rece…
Matched conditions: BACTERIAL INFECTIONS
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Heart infection survivors test exercise rehab in new study
Knowledge-focused Recruiting nowThis study looks at how a 12-week exercise program affects the health and quality of life of 50 people who had a serious heart infection called infective endocarditis. Participants will fill out surveys, do interviews, and take physical tests before, during, and up to a year afte…
Matched conditions: BACTERIAL INFECTIONS
Phase: NA • Sponsor: Region Halland • Aim: Knowledge-focused
Last updated May 01, 2026 15:56 UTC
-
New antibiotic candidate JKN2501 begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called JKN2501 in 66 healthy adults to see if it is safe and how the body processes it. The drug is being developed to fight bacterial infections like urinary tract and lung infections. Participants will receive either the drug or a pl…
Matched conditions: BACTERIAL INFECTIONS
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC
-
New antibiotic safety study for kidney patients launches
Knowledge-focused Recruiting nowThis early-stage study is testing a new antibiotic called Cefiderocol/Xeruborbactam in 40 adults with different levels of kidney function, including those on dialysis. The main goal is to see how safe the drug is and how the body processes it after a single dose. This information…
Matched conditions: BACTERIAL INFECTIONS
Phase: PHASE1 • Sponsor: Qpex Biopharma, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:15 UTC